Goldman Sachs Group Inc. reduced its stake in shares of LHC Group (NASDAQ:LHCG) by 15.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 48,808 shares of the health services provider’s stock after selling 9,166 shares during the period. Goldman Sachs Group Inc. owned 0.27% of LHC Group worth $2,631,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in LHCG. Invictus RG bought a new stake in shares of LHC Group during the first quarter valued at about $125,000. US Bancorp DE raised its stake in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares during the period. Mason Street Advisors LLC raised its stake in shares of LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock valued at $188,000 after buying an additional 228 shares during the period. Sawgrass Asset Management LLC bought a new stake in shares of LHC Group during the first quarter valued at about $241,000. Finally, UBS Asset Management Americas Inc. bought a new stake in shares of LHC Group during the first quarter valued at about $248,000. Institutional investors and hedge funds own 84.95% of the company’s stock.
LHC Group (NASDAQ LHCG) traded up 0.70% during trading on Friday, reaching $64.31. 97,793 shares of the company’s stock traded hands. The firm has a market capitalization of $1.18 billion, a PE ratio of 28.46 and a beta of 0.77. The firm has a 50 day moving average of $63.27 and a 200 day moving average of $57.46. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35.
LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm had revenue of $260.20 million during the quarter, compared to the consensus estimate of $254.10 million. During the same period last year, the firm posted $0.52 EPS. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis. Equities analysts forecast that LHC Group will post $2.39 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This report was posted by BNB Daily and is the sole property of of BNB Daily. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/lhc-group-nasdaqlhcg-shares-sold-by-goldman-sachs-group-inc-updated-updated.html.
LHCG has been the topic of a number of recent research reports. Royal Bank Of Canada restated a “buy” rating and set a $69.00 price target on shares of LHC Group in a research report on Friday, May 5th. Benchmark Co. boosted their price target on shares of LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, June 8th. Jefferies Group LLC restated a “buy” rating and set a $65.00 price target (up from $56.00) on shares of LHC Group in a research report on Friday, May 5th. BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Finally, Stephens set a $69.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research report on Saturday, May 6th. Nine research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of $65.75.
In other LHC Group news, Director Coliseum Capital Management, L sold 14,450 shares of the firm’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $65.69, for a total transaction of $949,220.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the sale, the chief operating officer now directly owns 114,235 shares in the company, valued at $7,421,847.95. The disclosure for this sale can be found here. Insiders have sold a total of 546,207 shares of company stock valued at $33,813,733 over the last 90 days. 14.80% of the stock is currently owned by insiders.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.